Stocks
Incyte Financial Statements (INCY) |
||||||||||
| Incytesmart-lab.ru | % | 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 09.02.2021 | 08.02.2022 | 07.02.2023 | 31.12.2023 | 16.02.2024 | 30.07.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 2 667 | 2 986 | 3 395 | 3 696 | 3 696 | 3 951 | |||
| Operating Income, bln rub | -240.3 | 585.8 | 579.4 | 620.5 | 620.5 | -10.8 | ||||
| EBITDA, bln rub | ? | -217.1 | 611.2 | 631.5 | 904.7 | 904.7 | 252.0 | |||
| Net profit, bln rub | ? | -295.7 | 948.6 | 340.7 | 597.6 | 597.6 | 127.1 | |||
| OCF, bln rub | ? | -124.6 | 749.5 | 969.9 | 496.5 | 496.5 | -61.3 | |||
| CAPEX, bln rub | ? | 187.4 | 181.0 | 77.8 | 47.5 | 47.5 | 69.6 | |||
| FCF, bln rub | ? | -312.0 | 568.5 | 892.1 | 449.0 | 449.0 | -130.9 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 2 776 | 2 235 | 2 596 | 2 791 | 2 791 | 3 639 | ||||
| Cost of production, bln rub | 131.3 | 151.0 | 207.0 | 255.0 | 255.0 | 293.6 | ||||
| R&D, bln rub | 2 216 | 1 458 | 1 586 | 1 628 | 1 628 | 2 457 | ||||
| Interest expenses, bln rub | 2.17 | 1.91 | 2.67 | 2.55 | 2.55 | 2.70 | ||||
| Assets, bln rub | 3 561 | 4 933 | 5 841 | 6 782 | 6 782 | 4 662 | ||||
| Net Assets, bln rub | ? | 2 611 | 3 770 | 4 370 | 5 190 | 5 190 | 2 997 | |||
| Debt, bln rub | 34.9 | 34.3 | 44.6 | 38.3 | 38.3 | 37.5 | ||||
| Cash, bln rub | 1 801 | 2 348 | 3 239 | 3 656 | 3 656 | 1 519 | ||||
| Net debt, bln rub | -1 767 | -2 314 | -3 194 | -3 618 | -3 618 | -1 482 | ||||
| Ordinary share price, rub | 87.0 | 73.4 | 80.3 | 62.8 | 62.8 | 54.0 | ||||
| Number of ordinary shares, mln | 218.1 | 220.4 | 222.0 | 225.9 | 223.6 | 218.2 | ||||
| Market cap, bln rub | 18 968 | 16 179 | 17 831 | 14 186 | 14 042 | 11 775 | ||||
| EV, bln rub | ? | 17 201 | 13 865 | 14 637 | 10 568 | 10 424 | 10 293 | |||
| Book value, bln rub | 2 283 | 3 464 | 4 085 | 4 911 | 4 911 | 2 728 | ||||
| EPS, rub | ? | -1.36 | 4.30 | 1.53 | 2.65 | 2.67 | 0.58 | |||
| FCF/share, rub | -1.43 | 2.58 | 4.02 | 1.99 | 2.01 | -0.60 | ||||
| BV/share, rub | 10.5 | 15.7 | 18.4 | 21.7 | 22.0 | 12.5 | ||||
| EBITDA margin, % | ? | -8.14% | 20.5% | 18.6% | 24.5% | 24.5% | 6.38% | |||
| Net margin, % | ? | -11.1% | 31.8% | 10.0% | 16.2% | 16.2% | 3.22% | |||
| FCF yield, % | ? | -1.64% | 3.51% | 5.00% | 3.17% | 3.20% | -1.11% | |||
| ROE, % | ? | -11.3% | 25.2% | 7.80% | 11.5% | 11.5% | 4.24% | |||
| ROA, % | ? | -8.30% | 19.2% | 5.83% | 8.81% | 8.81% | 2.73% | |||
| P/E | ? | -64.1 | 17.1 | 52.3 | 23.7 | 23.5 | 92.6 | |||
| P/FCF | -60.8 | 28.5 | 20.0 | 31.6 | 31.3 | -89.9 | ||||
| P/S | ? | 7.11 | 5.42 | 5.25 | 3.84 | 3.80 | 2.98 | |||
| P/BV | ? | 8.31 | 4.67 | 4.36 | 2.89 | 2.86 | 4.32 | |||
| EV/EBITDA | ? | -79.2 | 22.7 | 23.2 | 11.7 | 11.5 | 40.8 | |||
| Debt/EBITDA | 8.14 | -3.79 | -5.06 | -4.00 | -4.00 | -5.88 | ||||
| R&D/CAPEX, % | 1 183% | 805.6% | 2 038% | 3 428% | 3 428% | 3 528% | ||||
| CAPEX/Revenue, % | 7.03% | 6.06% | 2.29% | 1.28% | 1.28% | 1.76% | ||||
| Incyte shareholders | ||||||||||
